---
title: "Hong Kong's Micro-Cap Survival Playbook: Suspensions, Pivot and Capital Shuffles"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/301686191.md"
description: "Micro-cap stocks navigate survival strategies through suspensions and pivots. Eternal Beauty advances delisting after six-month halt, Du Fu Wine shifts to lending, China Hanking accelerates gold project, and ZJLD Group hits 17 billion yuan in alliance orders. Sector divergence intensifies amid market skepticism."
datetime: "2026-10-13T09:25:44.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/301686191.md)
  - [en](https://longbridge.com/en/news/301686191.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/301686191.md)
generator: "portal-rs"
---

# Hong Kong's Micro-Cap Survival Playbook: Suspensions, Pivot and Capital Shuffles

Hong Kong's micro-cap market is rewriting survival rules through unconventional pivots. Eternal Beauty (6883.HK) advances delisting resolution after six months of trading suspension, contrasting sharply with ZJLD Group (9688.HK) celebrating 17 billion yuan in alliance orders within 500 days. Du Fu Wine (986.HK) surged 9% following capital restructuring into lending business while China Hanking (3788.HK) accelerates equipment delivery for its Australian gold project targeting first production in Q1 2028. Youran Dairy (9858.HK) reported mid-year profits yet tumbled 10% in a single session amid raw milk cycle optimism, reflecting market skepticism. Xtep International (6979.HK) maintains growth in professional sports segment despite being flagged in October's 'undervalued stocks' watchlist. Zai Lab (1368.HK) navigates biotech sector volatility ahead of ESMO conference catalysts, while Xinjiang Xinxin Mining (3833.HK) posted 248% net profit surge from parent restructuring. A Hong Kong civil engineering contractor (8217.HK) faces revenue contraction, emblematic of micro-cap sector challenges.

### Related Stocks

- [03788.HK](https://longbridge.com/en/quote/03788.HK.md)
- [09858.HK](https://longbridge.com/en/quote/09858.HK.md)
- [00986.HK](https://longbridge.com/en/quote/00986.HK.md)
- [03833.HK](https://longbridge.com/en/quote/03833.HK.md)
- [08217.HK](https://longbridge.com/en/quote/08217.HK.md)
- [06883.HK](https://longbridge.com/en/quote/06883.HK.md)
- [06979.HK](https://longbridge.com/en/quote/06979.HK.md)
- [01368.HK](https://longbridge.com/en/quote/01368.HK.md)
- [09688.HK](https://longbridge.com/en/quote/09688.HK.md)

## Related News & Research

- [JP Morgan maintains Zai Lab at Overweight, raises price target to $37 from $36](https://longbridge.com/en/news/306164500.md)
- [Huachuang Securities Reaffirms Their Buy Rating on ZJLD Group, Inc. (6979)](https://longbridge.com/en/news/306080379.md)
- [Zai Lab Announces Participation in Investor Conferences in November 2026 | ZLAB Stock News](https://longbridge.com/en/news/305507532.md)
- [Zai Lab reports sustained biomarker inhibition with ZL-1503 in Phase 1 trial](https://longbridge.com/en/news/305458594.md)
- [Zai Lab Grants Options and Restricted Share Units to Employees](https://longbridge.com/en/news/305062145.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**